| 1. |  AUSTAR Lifesciences Limited Shanghai, China | CDMO | Commercial | VIEW |
| 2. |  Aspen Pharmacare Holdings Limited uMhlanga, South Africa | Pharma | Commercial (Focus on post-patent branded generics rather than R&D pipeline) | VIEW |
| 3. |  CEVA Logistics Marseille, France | CRO | Commercial | VIEW |
| 4. |  CSL Limited Melbourne, Australia | Pharma | Commercial | VIEW |
| 5. |  CSL Limited (CSL Behring is the largest division) Melbourne, Australia (corporate); King of Prussia, USA (CSL Behring) | Pharma | Phase 1 through Commercial | VIEW |
| 6. |  Cytiva Marlborough, Massachusetts, USA | MedTech | Commercial | VIEW |
| 7. |  Efficient Pharma Management Corp. (EffPha) Taipei City, Taiwan | CRO | Commercial | VIEW |
| 8. |  GSK plc London, United Kingdom | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 9. |  Hayya Life Science Jakarta, Indonesia | CRO | Commercial | VIEW |
| 10. |  | Digital Health | Commercial | VIEW |
| 11. |  IBS Co., Ltd. Suwon, South Korea | CRO | Commercial | VIEW |
| 12. |  | CRO | Commercial | VIEW |
| 13. |  LG Business Research Seoul, South Korea | Biotech | Commercial | VIEW |
| 14. |  MSD Rahway, New Jersey, USA | Pharma | Commercial | VIEW |
| 15. |  Merck & Co., Inc. Rahway, New Jersey, United States | Pharma | Phase 1-Phase 3 and Commercial | VIEW |
| 16. |  Parexel Raleigh, North Carolina, USA | CRO | Phase I-IV (as a CRO, Parexel manages client pipelines, not its own) | VIEW |
| 17. |  Pfizer New York, United States | Pharma | Phase 1-3 and pending approval | VIEW |
| 18. |  Process Automation Solutions (PA) Ludwigshafen, Germany / Greenville, SC, USA | CDMO | Commercial | VIEW |
| 19. |  | CRO | Commercial | VIEW |
| 20. |  | Pharma | Preclinical through Phase 3 | VIEW |
| 21. |  Takeda Pharmaceutical Company Tokyo, Japan | Pharma | Phase 3 | VIEW |
| 22. |  WriteSource Medical Pty Ltd North Sydney, Australia | CRO | Commercial | VIEW |